BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30876449)

  • 1. IRF2-INPP4B-mediated autophagy suppresses apoptosis in acute myeloid leukemia cells.
    Zhang F; Li J; Zhu J; Liu L; Zhu K; Cheng S; Lv R; Zhang P
    Biol Res; 2019 Mar; 52(1):11. PubMed ID: 30876449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRF2-INPP4B axis inhibits apoptosis of acute myeloid leukaemia cells via regulating T helper 1/2 cell differentiation.
    Zhang F; Zhu K; Liu L; Zhu J; Li J; Zhang P; Hu Z; Yuan Y
    Cell Biochem Funct; 2020 Jul; 38(5):582-590. PubMed ID: 32115737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRF2-INPP4B axis participates in the development of acute myeloid leukemia by regulating cell growth and survival.
    Zhang F; Zhu J; Li J; Zhu F; Zhang P
    Gene; 2017 Sep; 627():9-14. PubMed ID: 28579269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes derived from human bone marrow mesenchymal stem cells transfer miR-222-3p to suppress acute myeloid leukemia cell proliferation by targeting IRF2/INPP4B.
    Zhang F; Lu Y; Wang M; Zhu J; Li J; Zhang P; Yuan Y; Zhu F
    Mol Cell Probes; 2020 Jun; 51():101513. PubMed ID: 31968218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia.
    Dzneladze I; He R; Woolley JF; Son MH; Sharobim MH; Greenberg SA; Gabra M; Langlois C; Rashid A; Hakem A; Ibrahimova N; Arruda A; Löwenberg B; Valk PJ; Minden MD; Salmena L
    Leukemia; 2015 Jul; 29(7):1485-95. PubMed ID: 25736236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA LINC00265/miR-485-5p/IRF2-mediated autophagy suppresses apoptosis in acute myeloid leukemia cells.
    Zhang F; Li Q; Zhu K; Zhu J; Li J; Yuan Y; Zhang P; Zhou L; Liu L
    Am J Transl Res; 2020; 12(6):2451-2462. PubMed ID: 32655783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia.
    Jin H; Yang L; Wang L; Yang Z; Zhan Q; Tao Y; Zou Q; Tang Y; Xian J; Zhang S; Jing Y; Zhang L
    J Exp Clin Cancer Res; 2018 Jan; 37(1):8. PubMed ID: 29343273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA SENCR facilitates the progression of acute myeloid leukemia through the miR-4731-5p/IRF2 pathway.
    Han C; Qi Y; She Y; Zhang M; Xie H; Zhang J; Zhao Z; Peng C; Liu Y; Lin Y; Wang J; Zeng D
    Pathol Res Pract; 2023 May; 245():154483. PubMed ID: 37120908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway.
    Li D; Yang J; Ma H; Sun C; Feng R
    J Cell Biochem; 2018 Dec; 119(12):9899-9909. PubMed ID: 30132953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting PLK1 induces autophagy of acute myeloid leukemia cells via mammalian target of rapamycin pathway dephosphorylation.
    Tao YF; Li ZH; Du WW; Xu LX; Ren JL; Li XL; Fang F; Xie Y; Li M; Qian GH; Li YH; Li YP; Li G; Wu Y; Feng X; Wang J; He WQ; Hu SY; Lu J; Pan J
    Oncol Rep; 2017 Mar; 37(3):1419-1429. PubMed ID: 28184925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of Inositol Polyphosphate 4-Phosphatase Type II Expression in Colorectal Carcinoma.
    Sung JY; Na K; Kim HS
    Anticancer Res; 2017 Oct; 37(10):5525-5531. PubMed ID: 28982866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of INPP4B gene transfection combined with PARP inhibitor on castration therapy-resistant prostate cancer cell line, PC3.
    Ding H; Sun Y; Hou Y; Li L
    Urol Oncol; 2014 Jul; 32(5):720-6. PubMed ID: 24837011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cytosine arabinoside-resistant human myeloid leukemia cell death through autophagy regulation by hydroxychloroquine.
    Kim Y; Eom JI; Jeung HK; Jang JE; Kim JS; Cheong JW; Kim YS; Min YH
    Biomed Pharmacother; 2015 Jul; 73():87-96. PubMed ID: 26211587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML.
    Rijal S; Fleming S; Cummings N; Rynkiewicz NK; Ooms LM; Nguyen NY; Teh TC; Avery S; McManus JF; Papenfuss AT; McLean C; Guthridge MA; Mitchell CA; Wei AH
    Blood; 2015 Apr; 125(18):2815-24. PubMed ID: 25736313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPK-ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells.
    Jang JE; Eom JI; Jeung HK; Cheong JW; Lee JY; Kim JS; Min YH
    Clin Cancer Res; 2017 Jun; 23(11):2781-2794. PubMed ID: 27864418
    [No Abstract]   [Full Text] [Related]  

  • 16. l-Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH)
    Song JH; Park E; Kim MS; Cho KM; Park SH; Lee A; Song J; Kim HJ; Koh JT; Kim TS
    Int J Cancer; 2017 May; 140(10):2364-2374. PubMed ID: 28224619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INPP4B-mediated DNA repair pathway confers resistance to chemotherapy in acute myeloid leukemia.
    Wang P; Ma D; Wang J; Fang Q; Gao R; Wu W; Cao L; Hu X; Zhao J; Li Y
    Tumour Biol; 2016 Sep; 37(9):12513-12523. PubMed ID: 27342972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia.
    Nakamura S; Hirano I; Okinaka K; Takemura T; Yokota D; Ono T; Shigeno K; Shibata K; Fujisawa S; Ohnishi K
    Carcinogenesis; 2010 Nov; 31(11):2012-21. PubMed ID: 20823107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The change of nuclear LC3 distribution in acute myeloid leukemia cells.
    Guo W; Jin J; Pan J; Yao R; Li X; Huang X; Ma Z; Huang S; Yan X; Jin J; Dong A
    Exp Cell Res; 2018 Aug; 369(1):69-79. PubMed ID: 29752949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SHIP1 is targeted by miR-155 in acute myeloid leukemia.
    Xue H; Hua LM; Guo M; Luo JM
    Oncol Rep; 2014 Nov; 32(5):2253-9. PubMed ID: 25175984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.